Explore 3 Stock Ideas & Industry Insights Download Free Report

Trulieve Cannabis Corp

Healthcare CA TRUL

NoneCAD
0.00(0%)

Last update at 2026-06-26T21:11:54.581802Z

Day Range

--
LowHigh

52 Week Range

4.4516.35
LowHigh

Fundamentals

  • Previous Close 16.14
  • Market Cap1834.61M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA321.72M
  • Revenue TTM1181.18M
  • Revenue Per Share TTM6.17
  • Gross Profit TTM 711.17M
  • Diluted EPS TTM-0.8

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 91.47M 42.71M -284.53700M -43.30000M 163.51M
Minority interest 5.87M 5.47M 6.34M 6.70M 0.59M
Net income -116.38100M -155.10500M -526.79600M -246.10000M 18.03M
Selling general administrative 445.21M 510.45M 386.16M 454.60M 315.72M
Selling and marketing expenses - - - - -
Gross profit 711.17M 715.75M 588.63M 682.00M 566.13M
Reconciled depreciation 173.40M 177.89M 180.99M 119.40M 78.22M
Ebit - - - 133.76M 261.95M
Ebitda - - - 155.90M 276.51M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 148.32M 92.49M 92.64M 108.00M 202.32M
Other operating expenses - - - - -
Interest expense 63.45M 62.19M 81.57M 79.80M 34.79M
Tax provision 208.11M 197.59M 151.36M 161.80M 146.06M
Interest income 14.52M 14.68M 6.16M 1.63M 0.20M
Net interest income -48.93300M -47.51500M -75.40500M -79.80000M -34.78700M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - 161.82M 146.70M
Total revenue 1181.18M 1186.49M 1129.19M 1239.80M 938.38M
Total operating expenses 1032.86M 1094.00M 1036.55M 1131.80M 736.07M
Cost of revenue 470.01M 470.75M 540.57M 557.80M 372.25M
Total other income expense net -7.91600M -2.25900M -301.77300M -71.50000M -4.02400M
Discontinued operations - - - -47.56200M -1.93900M
Net income from continuing ops -116.63600M -154.87500M -435.89500M -205.10000M 17.45M
Net income applicable to common shares - - - -246.06400M 18.03M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2696.10M 2870.27M 2729.05M 3399.00M 3410.87M
Intangible assets 798.37M 859.48M 917.19M 1012.60M 1117.98M
Earning assets - - - - -
Other current assets 25.50M 26.21M 23.73M 49.86M 27.54M
Total liab 1553.09M 1621.24M 1320.44M 1471.30M 1263.50M
Total stockholder equity 1161.23M 1261.29M 1414.47M 1931.20M 2145.82M
Deferred long term liab - - - - -
Other current liab 4.46M 9.44M 7.42M 100.26M 55.73M
Common stock - - - - -
Capital stock 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Retained earnings -912.12500M -795.74400M -640.63900M -113.84300M 137.72M
Other liab - - - 265.14M 277.17M
Good will 483.90M 483.90M 483.90M 791.50M 765.36M
Other assets - - - 27.40M 81.95M
Cash 255.53M 238.80M 201.37M 212.30M 230.65M
Cash and equivalents - - - - -
Total current liabilities 126.94M 138.49M 114.85M 209.70M 169.45M
Current deferred revenue - - - - -
Net debt - 241.38M 281.46M 436.10M 248.79M
Short term debt - - - - -
Short long term debt 4.08M 3.41M 3.76M 12.50M 10.05M
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - - 974.56M 957.90M
Total current assets 562.72M 604.56M 477.35M 592.95M 524.93M
Long term investments - - - - -
Net tangible assets - - - 127.02M 299.22M
Short term investments 0.00000M 60.39M 0.00000M - -
Net receivables 10.50M 8.29M 6.70M 6.51M 8.85M
Long term debt 227.58M 476.78M 479.07M 635.90M 469.38M
Inventory 242.30M 231.37M 213.12M 297.81M 209.94M
Accounts payable 26.78M 20.23M 28.25M 16.41M 14.34M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 11.93M 21.82M 12.39M 15.40M 18.31M
Deferred long term asset charges - - - - -
Non current assets total 2133.38M 2265.71M 2251.71M 2806.00M 2886.45M
Capital lease obligations 331.97M 344.27M 309.74M 380.90M 379.59M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 60.00M -60.00000M -37.47000M -215.05700M -215.18400M
Change to liabilities - - - 1.55M -14.30100M
Total cashflows from investing activities - - - -215.05700M -215.18400M
Net borrowings -393.34800M -15.74000M -174.29500M 159.90M 64.64M
Total cash from financing activities -270.49700M -33.43900M -175.58500M 177.80M 289.23M
Change to operating activities - - - 10.60M -33.10900M
Net income -116.38100M -155.10500M -526.80000M -246.10000M 18.00M
Change in cash 15.82M 31.43M -11.21400M -14.22500M 86.39M
Begin period cash flow 239.71M 207.98M 213.79M 233.10M 146.71M
End period cash flow 255.53M 239.71M 207.98M 218.87M 233.66M
Total cash from operating activities 272.82M 271.48M 201.84M 23.10M 12.90M
Issuance of capital stock 140.00M - 0.00000M 0.00000M 217.90M
Depreciation 173.40M 177.89M 180.99M 185.57M 78.22M
Other cashflows from investing activities - - - 1.47M -3.84000M
Dividends paid - - 0.05M 0.05M 0.00000M
Change to inventory -10.92800M -18.73500M 83.30M -83.43000M -19.57300M
Change to account receivables -3.72400M 0.74M -1.71200M -4.20600M -4.90100M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - -0.88200M -0.25100M
Change to netincome - - - 139.32M 1.51M
Capital expenditures 60.51M 154.66M 55.49M 182.73M 306.12M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 188.17M 234.88M 174.11M -55.72700M -84.86300M
Stock based compensation 20.47M 20.20M 10.57M 18.12M 9.25M
Other non cash items 25.04M 8.99M 75.66M 78.51M 13.94M
Free cash flow 212.31M 116.82M 146.35M -161.48700M -283.98300M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TRUL
Trulieve Cannabis Corp
- -% - - 2000.00 1.55 1.15 1.40 5.03
GTII
Green Thumb Industries Inc
0.27 2.58% 10.74 14.70 34.84 1.91 0.86 1.61 3.95
CL
Cresco Labs Inc
-0.02 1.71% 1.15 - 105.26 0.70 0.99 1.32 42.44
JUSH
Jushi Holdings Inc
0.01 1.47% 0.69 - 17.86 0.52 0.69 1.41 9.56
GRIN
Grown Rogue International Inc
-0.02 3.39% 0.57 23.50 - 3.62 4.10 3.13 11.19

Reports Covered

Stock Research & News

Profile

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.

Trulieve Cannabis Corp

3494 Martin Hurst Road, Tallahassee, FL, United States, 32312

Key Executives

Name Title Year Born
Ms. Kimberly Rivers J.D. Founder, Chairman & CEO 1978
Mr. Nilyum Jhala Chief Technology Officer 1977
Mr. Eric Raymond Powers III, J.D. Chief Legal Officer & Corporate Secretary 1969
Mr. Kyle Landrum Chief Production Officer 1986
Mr. Jason Barry Pernell President 1977
Mr. Jan Reese Chief Financial Officer NA
Ms. Joy Malivuk VP & Chief Accounting Officer 1975
Phil Buck Corporate Communications Manager NA
Mr. Timothy Morey Chief Sales Officer 1963
Mr. Michiel de Zwaan Chief Human Resources Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions